Status:
COMPLETED
LSA Reconstruction With Laser Fenestration During the TEVAR
Lead Sponsor:
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Conditions:
Type B Aortic Dissection
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study aims to evaluate the feasibility, effectiveness, and safety of in-situ laser-assisted fenestration on the left subclavian artery during the procedure of thoracic artery endovascular repair
Detailed Description
This study is a single-arm, prospective study. All patients with type B aortic dissection (TBAD) present with the proximal tear site located approximately close to the left subclavian artery and a rec...
Eligibility Criteria
Inclusion
- Male or non-pregnant female over 18 years of age;
- Type B Aortic Dissection;
- The left subclavian artery should be reconstructed during the TEVAR procedure.
- Patient is willing to provide informed consent and comply with the required follow up visits, testing schedule and medication regimen;
Exclusion
- Life expectancy of \< 5 years;
- Patients need open surgery repair for the aortic diseases.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03845829
Start Date
July 1 2018
End Date
November 20 2023
Last Update
February 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaichuang Ye
Shanghai, Shanghai Municipality, China, 200011